• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Nature's Sunshine Honored with Comparably Awards for Best Leadership Team and Best Career Growth

    6/17/24 8:30:00 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $NATR alert in real time by email

    Nature's Sunshine Products, Inc. has been recognized by Comparably with two prestigious workplace awards

    LEHI, Utah, June 17, 2024 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR), a leading natural health and wellness company offering high-quality herbal and nutritional products, has been recognized by Comparably with two prestigious workplace awards: Best Leadership Team—for a third consecutive year—and Best Career Growth. These honors highlight Nature's Sunshine's commitment to fostering an exceptional culture, engaging leaders to inspire excellence and providing opportunities for career growth.

    "We are very pleased to receive these awards from Comparably," said Terrence Moorehead, Nature's Sunshine CEO. "Our leadership team works tirelessly to create a culture of growth, collaboration, and success. This recognition is a testament to their efforts in driving our company forward while empowering our talented employees to reach their full potential."

    The Comparably Awards are based on anonymous ratings from employees over the past year, covering various aspects of workplace culture, leadership, and career development opportunities. Nature's Sunshine's impressive performance across these categories solidifies its reputation as an employer of choice in the natural health and wellness industry.

    "At Nature's Sunshine, we believe in investing in our people, as evidenced by the fact that our average employee tenure is over 10.7 years," said Tracee Comstock, SVP of Global Human Resources. "These awards reflect our commitment to developing strong leaders and providing our employees with the resources and support they need to grow professionally."  

    Nature's Sunshine has consistently earned accolades from Comparably, having received multiple awards over the past few years, including:      

    Nature's Sunshine has consistently earned accolades from Comparably, having received multiple awards over the past few years



















    For more information about Nature's Sunshine and its award-winning workplace culture, please visit www.naturessunshine.com/careers/.

    Feel Nature's Power

    About Nature's Sunshine Nature's Sunshine Products (NASDAQ:NATR), a leading natural health and wellness company, markets and distributes nutritional and personal care products in more than 40 countries. Nature's Sunshine manufactures most of its products through its own state-of-the-art facilities to ensure its products continue to set the standard for the highest quality, safety, and efficacy on the market today. Additional information about the Company can be found at www.naturessunshine.com. Our Power Line products include,

    • Power Meal

      Provides an exclusive combination of 25 grams of muscle-fueling, plant-based protein with stress-supporting adaptogens, immune-boosting mushrooms, gut-building plant fibers and antioxidant-rich superfoods.
    • Power Beets

      Uniquely blending the nitric oxide-boosting nitrates in beet root with the proven circulatory benefits of polyphenol-rich herbs and superfoods, Power Beets supports energy, alertness, circulation and performance.

    • Power Greens

      Packed with 200+ plant-based nutrients in every serving, Power Greens provides superfood fruits and greens blended with fiber, adaptogenic herbs and natural antioxidants for superior wholefood nutrition.

    About Comparably Comparably (www.comparably.com) is a leading workplace culture and corporate brand reputation platform with over 15 million anonymous employee ratings on 70,000 companies. With the most comprehensive data on large and SMB organizations in nearly 20 different workplace categories -- based on gender, ethnicity, age, experience, industry, location, education -- it is one of the most used SaaS platforms for employer branding and a trusted third-party site for workplace culture and compensation.

    Investor Relations:

    Gateway Group, Inc.

    Cody Slach

    1-949-574-3860

    [email protected]

    Photos accompanying this announcement are available at

    https://www.globenewswire.com/NewsRoom/AttachmentNg/229eb80a-2075-42b6-8e66-10684e3a299c

    https://www.globenewswire.com/NewsRoom/AttachmentNg/b5bcd6d5-d430-42a6-a1ff-bdb1cf3d6716

    https://www.globenewswire.com/NewsRoom/AttachmentNg/0187159a-d0de-4959-9415-2706e30b27cb



    Primary Logo

    Get the next $NATR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NATR

    DatePrice TargetRatingAnalyst
    5/7/2025$19.00Buy
    DA Davidson
    9/13/2024$18.00Buy
    Canaccord Genuity
    3/9/2022$24.00 → $24.50Buy
    DA Davidson
    11/5/2021$22.00 → $24.00Buy
    DA Davidson
    10/15/2021$22.00Buy
    DA Davidson
    More analyst ratings

    $NATR
    SEC Filings

    View All

    SEC Form DEF 14A filed by Nature's Sunshine Products Inc.

    DEF 14A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

    3/27/26 5:15:12 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEFA14A filed by Nature's Sunshine Products Inc.

    DEFA14A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

    3/27/26 5:16:08 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 10-K filed by Nature's Sunshine Products Inc.

    10-K - NATURES SUNSHINE PRODUCTS INC (0000275053) (Filer)

    3/10/26 5:10:54 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $NATR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Fuller Kevin Gregory

    4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

    3/26/26 2:11:31 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Fritz Erich A

    4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

    3/26/26 2:11:07 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Romanzi Kenneth G.

    4 - NATURES SUNSHINE PRODUCTS INC (0000275053) (Issuer)

    3/26/26 2:10:27 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $NATR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nature's Sunshine Reports Strong Fourth Quarter and Full Year 2025 Financial Results

    LEHI, Utah, March 10, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine" and/or the "Company"), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Summary vs. Same Year-Ago Quarter Net sales were up 4.7% to $123.8 million compared to $118.2 million (up 3.8% in constant currency).GAAP net income attributable to common shareholders of $4.1 million, or $0.23 per diluted share, compared to net loss of $0.3 million, or $(0.02) per diluted share.Adjusted EBITDA up 16% to $11.9 million compar

    3/10/26 4:05:00 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nature's Sunshine Sets Fourth Quarter 2025 Conference Call for Tuesday, March 10, 2026, at 5:00 p.m. ET

    LEHI, Utah, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine") (the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, will conduct a conference call on Tuesday, March 10, 2026, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the fourth quarter and full year ended December 31, 2025. The Company will report its financial results in a press release prior to the conference call. Nature's Sunshine CEO Kenneth Romanzi and CFO Shane Jones will host the conference call, followed by a question and answer period. Date: Tuesday, March 10, 2026Time: 5:00 p.m. Eastern time

    2/24/26 4:05:00 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Euromonitor International Names Synergy Pro-Argi-9+ the World's #1 L-Arginine Supplement

    LEHI, Utah, Dec. 15, 2025 (GLOBE NEWSWIRE) -- Synergy Worldwide, a division of Nature's Sunshine Products, today announced that Euromonitor International has named Pro-Argi-9+ the world's #1 l-arginine supplement,* reinforcing the product's growing global momentum and Synergy's leadership in the health and wellness space. Synergy's flagship product, Pro-Argi-9+ offers a unique formula with clinically researched ingredients featuring L-Arginine to support nitric oxide production and promote healthy circulation and blood flow throughout the body. With this certification, Pro-Argi-9+ will continue to serve as the cornerstone of Synergy's mission to help people push the boundaries of their po

    12/15/25 8:00:00 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $NATR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    DA Davidson resumed coverage on Nature's Sunshine with a new price target

    DA Davidson resumed coverage of Nature's Sunshine with a rating of Buy and set a new price target of $19.00

    5/7/25 8:37:48 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Canaccord Genuity initiated coverage on Nature's Sunshine with a new price target

    Canaccord Genuity initiated coverage of Nature's Sunshine with a rating of Buy and set a new price target of $18.00

    9/13/24 7:38:59 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    DA Davidson reiterated coverage on Natures Sunshine Products with a new price target

    DA Davidson reiterated coverage of Natures Sunshine Products with a rating of Buy and set a new price target of $24.50 from $24.00 previously

    3/9/22 9:23:08 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $NATR
    Financials

    Live finance-specific insights

    View All

    Nature's Sunshine Reports Strong Fourth Quarter and Full Year 2025 Financial Results

    LEHI, Utah, March 10, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine" and/or the "Company"), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Summary vs. Same Year-Ago Quarter Net sales were up 4.7% to $123.8 million compared to $118.2 million (up 3.8% in constant currency).GAAP net income attributable to common shareholders of $4.1 million, or $0.23 per diluted share, compared to net loss of $0.3 million, or $(0.02) per diluted share.Adjusted EBITDA up 16% to $11.9 million compar

    3/10/26 4:05:00 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nature's Sunshine Sets Fourth Quarter 2025 Conference Call for Tuesday, March 10, 2026, at 5:00 p.m. ET

    LEHI, Utah, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine") (the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, will conduct a conference call on Tuesday, March 10, 2026, at 5:00 p.m. Eastern time (3:00 p.m. Mountain time) to discuss its financial results for the fourth quarter and full year ended December 31, 2025. The Company will report its financial results in a press release prior to the conference call. Nature's Sunshine CEO Kenneth Romanzi and CFO Shane Jones will host the conference call, followed by a question and answer period. Date: Tuesday, March 10, 2026Time: 5:00 p.m. Eastern time

    2/24/26 4:05:00 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nature's Sunshine Reports Strong Third Quarter 2025 Results

    Net Sales up 12% to $128.3 Million, GAAP EPS up 30% to $0.30Adjusted EBITDA up 42% to $15.2 MillionRaised Full-Year Outlook LEHI, Utah, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine"), a leading manufacturer of high-quality herbal and nutritional supplements, reported financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Summary vs. Same Year-Ago Quarter Net sales were up 12% to $128.3 million compared to $114.6 million (up 10% in constant currency).Gross profit margin increased 200 basis points to 73.3% compared to 71.3%.GAAP net income attributable to common shareholders was $5.3 million, o

    11/6/25 4:05:00 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $NATR
    Leadership Updates

    Live Leadership Updates

    View All

    Nature's Sunshine Appoints Erich Fritz as Executive Vice President of Global Supply Chain

    LEHI, Utah, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine") (the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, today announced that Erich Fritz has been named Executive Vice President, Global Supply Chain, effective December 8, 2025. Mr. Fritz will report directly to Ken Romanzi, the Company's Chief Executive Officer. Mr. Fritz brings over 40 years of executive experience in operations, supply chain, and business development, with a proven track record of driving growth, operational efficiency, and innovation at leading consumer goods companies. His leadership spans Fortune 500 organizations an

    12/4/25 10:00:00 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nature's Sunshine Appoints Kenneth Romanzi as CEO

    Mr. Romanzi Brings Extensive Leadership and Operational Experience at Prominent, Large-Scale Consumer Packaged Goods Companies and Proven Track Record of Driving Growth and Value Creation LEHI, Utah, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine") (the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, today announced that its Board of Directors has appointed Kenneth Romanzi to succeed Terrence Moorehead as Chief Executive Officer. Mr. Romanzi will assume the role and become a member of the Nature's Sunshine Board of Directors on October 29, 2025. Mr. Romanzi is an experienced CEO and operator with

    10/15/25 9:00:00 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Nature's Sunshine Announces Leadership Transition Plan

    Board Initiates CEO Search Process Terrence Moorehead to Step Down as President and CEO, Once Successor Appointed Company Reaffirms Full Year 2025 Outlook LEHI, Utah, June 02, 2025 (GLOBE NEWSWIRE) -- Nature's Sunshine Products, Inc. (NASDAQ:NATR) ("Nature's Sunshine") (the "Company"), a leading manufacturer of high-quality herbal and nutritional supplements, today announced that Terrence Moorehead has notified the Company's Board of Directors (the "Board") of his decision to step down as President and Chief Executive Officer, effective upon the appointment of a successor. At that time, Mr. Moorehead will also resign as a member of the Board of Directors. The Nature's Sunshine Board ha

    6/2/25 9:00:00 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $NATR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Nature's Sunshine Products Inc. (Amendment)

    SC 13G/A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Subject)

    2/12/24 10:37:49 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Nature's Sunshine Products Inc. (Amendment)

    SC 13G/A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Subject)

    1/31/24 11:56:05 AM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G/A filed by Nature's Sunshine Products Inc. (Amendment)

    SC 13G/A - NATURES SUNSHINE PRODUCTS INC (0000275053) (Subject)

    2/13/23 2:42:04 PM ET
    $NATR
    Biotechnology: Pharmaceutical Preparations
    Health Care